These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 32250982)
1. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid. Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982 [TBL] [Abstract][Full Text] [Related]
2. Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section? Kram JJF; Greer DM; Cabrera O; Burlage R; Forgie MM; Siddiqui DS Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():334-341. PubMed ID: 28122314 [TBL] [Abstract][Full Text] [Related]
3. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women. Swank ML; Wing DA; Nicolau DP; McNulty JA Am J Obstet Gynecol; 2015 Sep; 213(3):415.e1-8. PubMed ID: 26003059 [TBL] [Abstract][Full Text] [Related]
4. Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients. Ryan RL; Jackson D; Hopkins G; Eley V; Christensen R; Van Zundert AAJ; Wallis SC; Lipman J; Parker SL; Roberts JA Antimicrob Agents Chemother; 2022 Jul; 66(7):e0041922. PubMed ID: 35762797 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery. Young OM; Shaik IH; Twedt R; Binstock A; Althouse AD; Venkataramanan R; Simhan HN; Wiesenfeld HC; Caritis SN Am J Obstet Gynecol; 2015 Oct; 213(4):541.e1-7. PubMed ID: 26103528 [TBL] [Abstract][Full Text] [Related]
6. Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery. Pevzner L; Swank M; Krepel C; Wing DA; Chan K; Edmiston CE Obstet Gynecol; 2011 Apr; 117(4):877-882. PubMed ID: 21422859 [TBL] [Abstract][Full Text] [Related]
7. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. Brill MJ; Houwink AP; Schmidt S; Van Dongen EP; Hazebroek EJ; van Ramshorst B; Deneer VH; Mouton JW; Knibbe CA J Antimicrob Chemother; 2014 Mar; 69(3):715-23. PubMed ID: 24214905 [TBL] [Abstract][Full Text] [Related]
8. Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug. Stitely M; Sweet M; Slain D; Alons L; Holls W; Hochberg C; Briggs F Surg Infect (Larchmt); 2013 Oct; 14(5):455-9. PubMed ID: 23859672 [TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery. Grupper M; Kuti JL; Swank ML; Maggio L; Hughes BL; Nicolau DP J Clin Pharmacol; 2017 Jun; 57(6):712-719. PubMed ID: 27925657 [TBL] [Abstract][Full Text] [Related]
10. Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial. Maggio L; Nicolau DP; DaCosta M; Rouse DJ; Hughes BL Obstet Gynecol; 2015 May; 125(5):1205-1210. PubMed ID: 25932849 [TBL] [Abstract][Full Text] [Related]
11. A Retrospective Exploration of Pre-operative Antibiotic Prophylaxis with Cefazolin in Cesarean Sections: Implications for Obstetrics and Gynecologic Surgery. Abdel Halim AS; Ali MAM; Al Mamari R; Al Raisi F; Boufahja F; Chaudhary AA; Hegazy WAH Surg Infect (Larchmt); 2024 Sep; 25(7):513-520. PubMed ID: 38957977 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery. Elkomy MH; Sultan P; Drover DR; Epshtein E; Galinkin JL; Carvalho B Antimicrob Agents Chemother; 2014 Jun; 58(6):3504-13. PubMed ID: 24733461 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass. Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208 [TBL] [Abstract][Full Text] [Related]
14. Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial. Naik BI; Roger C; Ikeda K; Todorovic MS; Wallis SC; Lipman J; Roberts JA Br J Anaesth; 2017 Jun; 118(6):876-882. PubMed ID: 28505360 [TBL] [Abstract][Full Text] [Related]
15. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing. Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693 [TBL] [Abstract][Full Text] [Related]
16. Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery. Douglas A; Udy AA; Wallis SC; Jarrett P; Stuart J; Lassig-Smith M; Deans R; Roberts MS; Taraporewalla K; Jenkins J; Medley G; Lipman J; Roberts JA Antimicrob Agents Chemother; 2011 Nov; 55(11):5238-42. PubMed ID: 21859939 [TBL] [Abstract][Full Text] [Related]